Steris’ (STE) “Market Perform” Rating Reiterated at Raymond James Financial
Raymond James Financial reiterated their market perform rating on shares of Steris (NYSE:STE) in a research note issued to investors on Wednesday, MarketBeat reports. They currently have a $100.00 price target on the medical equipment provider’s stock.
Other equities analysts also recently issued reports about the company. KeyCorp restated a buy rating and issued a $91.00 target price on shares of Steris in a research note on Tuesday, October 17th. Zacks Investment Research upgraded Steris from a hold rating to a buy rating and set a $101.00 target price for the company in a research note on Monday, October 9th. Finally, TD Securities lifted their target price on Steris from C$14.00 to C$16.00 and gave the company a buy rating in a research note on Thursday, November 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of Buy and an average price target of $79.50.
Shares of Steris (NYSE STE) traded up $0.44 during mid-day trading on Wednesday, reaching $86.95. The company’s stock had a trading volume of 509,022 shares, compared to its average volume of 338,810. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.18 and a current ratio of 2.80. Steris has a 12 month low of $65.26 and a 12 month high of $93.39. The firm has a market capitalization of $7,395.27, a P/E ratio of 22.41 and a beta of 1.27.
Steris (NYSE:STE) last issued its earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 EPS for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.01). Steris had a net margin of 5.59% and a return on equity of 11.49%. The company had revenue of $634.20 million during the quarter, compared to analyst estimates of $629.02 million. During the same quarter in the previous year, the firm earned $0.89 earnings per share. The business’s revenue was down 1.9% on a year-over-year basis. analysts anticipate that Steris will post 4.06 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 20th. Stockholders of record on Wednesday, November 22nd were given a dividend of $0.31 per share. The ex-dividend date was Tuesday, November 21st. This represents a $1.24 annualized dividend and a dividend yield of 1.43%. Steris’s dividend payout ratio is presently 73.81%.
In other news, insider Michael J. Tokich sold 11,000 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $92.00, for a total transaction of $1,012,000.00. Following the completion of the transaction, the insider now directly owns 58,588 shares in the company, valued at $5,390,096. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP John Adam Zangerle sold 3,650 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total value of $321,200.00. The disclosure for this sale can be found here. Insiders own 2.55% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. The Manufacturers Life Insurance Company boosted its position in shares of Steris by 1.6% during the second quarter. The Manufacturers Life Insurance Company now owns 122,520 shares of the medical equipment provider’s stock worth $9,986,000 after buying an additional 1,963 shares during the period. State of Wisconsin Investment Board acquired a new position in shares of Steris during the second quarter worth approximately $1,360,000. Prudential Financial Inc. boosted its position in shares of Steris by 14.4% during the third quarter. Prudential Financial Inc. now owns 192,686 shares of the medical equipment provider’s stock worth $17,034,000 after buying an additional 24,220 shares during the period. Canada Pension Plan Investment Board boosted its position in shares of Steris by 13.2% during the third quarter. Canada Pension Plan Investment Board now owns 54,100 shares of the medical equipment provider’s stock worth $4,782,000 after buying an additional 6,300 shares during the period. Finally, Keybank National Association OH acquired a new position in shares of Steris during the third quarter worth approximately $554,000. Institutional investors and hedge funds own 89.40% of the company’s stock.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with Analyst Ratings Network's FREE daily email newsletter.